Sino Medical Sciences’ HT Supreme Stent System Gains Vietnamese Marketing Approval
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) announced that it has received marketing approval...
Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced a commercialization agreement with Bayer (ETR: BAYN),...
Major Policy Directions in China’s Healthcare Arena: A Comprehensive Breakdown
In a momentous address at the Third Session of the 14th National People’s Congress on...
RongCan Biotech’s mRNA HPV Vaccine Receives FDA Clinical Approval
China-based mRNA specialist RongCan (Shanghai) Biotech Co., Ltd announced that it has received clinical approval...
Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has formed a partnership with compatriot firm...
Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
China-based Lexenpharm has formed a partnership with compatriot firm Beijing Sun-Novo Pharmaceutical Research Co., Ltd...
Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China
China-based health services and distribution giant Baheal Pharmaceutical Group (SHE: 301015) last month reached an...
Zhejiang Huahai’s HB0034 Meets Primary Endpoint in GPP Study
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) announced that its multi-center, double-blinded, randomized, placebo-parallel...
CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
China-based CStone Pharmaceuticals (HKG: 2616) and Costa Rica-based drug maker and distributor SteinCares have entered...
Fosun Pharma’s 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd’s (SHA: 600196, HKG: 2196) subsidiary Fosun Adgenvax (Chengdu)...
Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
China-based Bio-Thera Solutions (SHA: 688177) has entered into a licensing agreement with World Medicine, granting...
Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) announced a significant partnership between its US...
Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies
US-based AI-powered biotech Gensaic, Inc. announced the signing of a licensing and discovery cooperation agreement...
MSD China Reorganizes to Boost Mature Product Lines
Anna Van Acker, Senior Vice-President of Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) and...
Suzhou Abogen’s RSV mRNA Vaccine IND Approved by China’s CDE
China-based nucleic acid drug developer Suzhou Abogen Biosciences announced that the Investigational New Drug (IND)...
CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D
China’s Center for Drug Evaluation (CDE) has released a notification to solicit feedback on its...
BeiGene’s Tevimbra Receives FDA Approval for ESCC Treatment
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), a multinational oncology company planning to change...
Organon’s 2024 Financial Report Shows Steady Growth in Women’s Health and Biosimilars
Women’s health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year...
AstraZeneca and Daiichi Sankyo’s Enhertu Shows Positive Results in Phase III Study
Partners AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) announced positive topline results from the...
Boehringer Ingelheim Appeals CNIPA’s Invalidation of Jardiance Patents
The Intellectual Property Court of the Supreme People’s Court of China issued a notice, holding...